Preliminary safety and antiviral activity of VIR-2218, an X-targeting HBV RNAi therapeutic, in chronic hepatitis B patients
Edward Gane, Young-Suk Lim, Pisit Tangkijvanich, James O’Beirne, Tien Huey Lim, Anna I. Bakardjiev, Xiao Ding, Lynn Connolly, Stephen Huang, Jae Il Kim, Phil Pang, Man‐Fung Yuen
Topics & Concepts
MedicineRNA interferenceVirologyChronic hepatitisHepatitis B virusAntiviral therapyImmunologyVirusBiologyRNAGeneticsGeneHepatitis B Virus StudiesHepatitis C virus researchLiver Disease Diagnosis and Treatment